申请人:Tidmarsh George
公开号:US20060276527A1
公开(公告)日:2006-12-07
Lonidamine or a lonidamine analog is administered with one or more additional anti-cancer agents or surgery or radiation to treat cancer or is administered alone or in combination to treat cancer, optionally in a sustained release formulation, and improve patient outcome.